Jubilant Life Sciences has been informed by the U.S. Food and Drug Administration (USFDA), in correspondence dated 13 March 2019, received on 21 March 2019 that the inspection from December 10-18, 2018 at the Jubilant Generics API manufacturing facility, in Nanjangud, Mysore, has been classified ...read more